Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus

Abstract Cardiovascular disease is one of the main causes of death in patients with systemic lupus erythematosus (SLE). On the other hand, sclerostin is a reliable and early biomarker of vascular calcification. This study aimed to estimate the association between sclerostin and two markers of cardio...

Full description

Bibliographic Details
Main Authors: Carlos Garcia-de los Ríos, Marta Medina-Casado, Antonio Díaz-Chamorro, María Sierras-Jiménez, Pablo Lardelli-Claret, Rafael Cáliz-Cáliz, José Mario Sabio
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-25651-y